Biorem Inc V.BRM

New Press Release - Biorem Reports 2023 Financial Results including $0.14 earnings per share

GUELPH, ON, April 11, 2024 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem's complete fiscal 2023 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com...read article.

[KnowledgeSeekr8]

There they are and here goes the stock price! I knew $2 could be well in hand with some good results. This company could be easily worth $35-$40 million market cap in the next 12 month if they start cashing in that backlog and continue with new orders. That would be approx $1.95-$2.58

[fergus2]

Congrats KnowledgeSeekr8, I know you've been a patient investor in this one for s while and hold a large position. Possibleidiot01 is another such type. Single malt for the both of you. Cheers, Fergus2

[Possibleidiot01]

What can I say, your target has pretty much been reached so I feel wealthier? My take on the results isn't as bullish as the markets where I think the company is trading on the outlook and management's capabilities ( which I wouldn't bet against and so I am not selling) . Revenues down year over year. Gross profit down year over year . Here's the biggest factor in the